Home > Name List By other > (2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-5-[[(1S,2R)-2-hydroxy-2, 3-dihydro-1H-inden-1-yl]amino]-5-oxopentyl]-N-tert-butyl-4-(pyrid...

CAS No 150378-17-9 , (2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-5-[[(1S,2R)-2-hydroxy-2,
3-dihydro-1H-inden-1-yl]amino]-5-oxopentyl]-N-tert-butyl-4-(pyridin-3-
ylmethyl)piperazine-2-carboxamide

  • Name: (2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-5-[[(1S,2R)-2-hydroxy-2,
    3-dihydro-1H-inden-1-yl]amino]-5-oxopentyl]-N-tert-butyl-4-(pyridin-3-
    ylmethyl)piperazine-2-carboxamide
  • Synonyms: Crixivan;(2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-5-[[(1S,2R)-2-hydroxy-2,
    3-dihydro-1H-inden-1-yl]amino]-5-oxopentyl]-N-tert-butyl-4-(pyridin-3-
    ylmethyl)piperazine-2-carboxamide; 1sgu; 150378-17-9; 1sdv; 1hsh; 1sdt; 1hsg;Compound J; 1sdu;
  • CAS Registry Number:
  • Density: 1.25 g/cm3
  • Refractive index: 1.636
  • Molecular Weight: 613.78948
  • InchiKey: CBVCZFGXHXORBI-PXQQMZJSSA-N
  • InChI: InChI=1S/C36H47N5O4/c1-36(2,
    3)39-35(45)31-24-40(22-26-12-9-15-37-21-26)16-17-41(31)23-29(42)19-28
    (18-25-10-5-4-6-11-25)34(44)38-33-30-14-8-7-13-27(30)20-32(33)43/h4-15,
    21,28-29,31-33,42-43H,16-20,22-24H2,1-3H3,(H,38,44)(H,39,45)/t28-,29+,
    31+,32-,33+/m1/s1
  • Molecular Formula: C36H47N5O4
  • Molecular Structure:CAS No:150378-17-9 (2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-5-[[(1S,2R)-2-hydroxy-2,<br />3-dihydro-1H-inden-1-yl]amino]-5-oxopentyl]-N-tert-butyl-4-(pyridin-3-<br />ylmethyl)piperazine-2-carboxamide
Search by region :

Select to

150378-17-9 Indinavir Sulfate

  • China Welpharm Co.,Ltd [Manufacturers]
  • Tel: +86-21-58690818 ,58690828
  • Fax: +86-21-58690838
  • Address: No. 2021 Tomson Bldg., 1 Keelung Rd., Pudong Shanghai, China Shanghai,ShanghaiChina
Contact Supplier

150378-17-9 Indinavir

  • China Kangrui BIO-TECH Co.,Ltd.(H.K.) [Manufacturers]
  • Tel: 0086-571-86680744
  • Fax: 0086-571-86680744
  • Address: 3-704, Xixi Fengshang, Wensan West Road, Hangzhou, Zhejiang, China Hangzhou,ZhejiangChina
Contact Supplier

150378-17-9 D-erythro-Pentonamide,2,3,5-trideoxy-N-[(1S,2R)-2,3-dihydro-2-hydroxy-1H-inden-1-yl]-5-[(2S)-2-[[(1,1-dimethylethyl)amino]carbonyl]-4-(3-pyridinylmethyl)-1-piperazinyl]-2-(phenylmethyl)-

  • China Xiamen Senborn BiochemiCal Co.,Ltd. [Manufacturers]
  • Tel: +86-(592)-622-6595
  • Fax: +86-0592-6226595 6226596 6226597
  • Address: Rm. 1005, Jinrong Building, Xingdong Road, Xinglin Jimei, Xiamen, Fujian 361002, XIAMEN,FUJIANChina
Contact Supplier

150378-17-9 D-erythro-Pentonamide,2,3,5-trideoxy-N-[(1S,2R)-2,3-dihydro-2-hydroxy-1H-inden-1-yl]-5-[(2S)-2-[[(1,1-dimethylethyl)amino]carbonyl]-4-(3-pyridinylmethyl)-1-piperazinyl]-2-(phenylmethyl)-

  • China Shanghai Chemchallenger Biotech Co., Ltd. [Manufacturers]
  • Tel: 0086-21-68110815
  • Fax: -0086-21-68110815
  • Address: Room 2056, Building 1, No. 1065, Jiaxin Road Shanghai China (Mainland) 201800 null,shanghaiChina
Contact Supplier

Select to

References of (2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-5-[[(1S,2R)-2-hydroxy-2,
3-dihydro-1H-inden-1-yl]amino]-5-oxopentyl]-N-tert-butyl-4-(pyridin-3-
ylmethyl)piperazine-2-carboxamide
Title: Indinavir
CAS Registry Number: 150378-17-9
CAS Name: 2,3,5-Trideoxy-N-[(1S,2R)-2,3-dihydro-2-hydroxy-1H-inden-1-yl]-5-[(2S)-2-[[(1,1-dimethylethyl)amino]carbonyl]-4-(3-pyridinylmethyl)-1-piperazinyl]-2-(phenylmethyl)-D-erythro-pentonamide
Synonyms: (aR,gS,2S)-a-benzyl-2-(tert-butylcarbamoyl)-g-hydroxy-N-[(1S,2R)-2-hydroxy-1-indanyl]-4-(3-pyridylmethyl)-1-piperazinevaleramide; N-(2(R)-hydroxy-1(S)-indanyl)-2(R)-(phenylmethyl)-4(S)-hydroxy-5-[1-[4-(3-pyridylmethyl)-2(S)-(N-tert-butylcarbamoyl)piperazinyl]]pentanamide
Molecular Formula: C36H47N5O4
Molecular Weight: 613.79
Percent Composition: C 70.45%, H 7.72%, N 11.41%, O 10.43%
Literature References: Member of the novel hydroxyaminopentane amide class of HIV-1 protease inhibitors. Prepn: J. P. Vacca et al., EP 541168; eidem, US 5413999 (1993, 1995 both to Merck & Co.); B. D. Dorsey et al., J. Med. Chem. 37, 3443 (1994). Diastereoselective synthesis: D. Askin et al., Tetrahedron Lett. 35, 673 (1994); P. E. Maligres et al., ibid. 36, 2195 (1995). Crystal structure of HIV-II protease complex: Z. Chen et al., J. Biol. Chem. 269, 26344 (1994). Antiviral activity and pharmacokinetics: J. P. Vacca et al., Proc. Natl. Acad. Sci. USA 91, 4096 (1994). HPLC determn in plasma and urine: E. Woolf et al., J. Chromatogr. A 692, 45 (1995). Metabolism in humans: S. K. Balani et al., Drug Metab. Dispos. 23, 266 (1995).
Properties: Occurs as monohydrate, crystals from wet ethyl or isopropyl acetate, loss of water below 100° followed by recrystallization of anhydrous form with mp 153-154°; second anhydrous form, mp 167.5-168°. Soly in water (mg/ml): 0.015 (unbuffered), >1.5 (pH 4.0). [a]D22 +24.1° (c = 0.0133 in chloroform).
Melting point: mp 153-154°; mp 167.5-168°
Optical Rotation: [a]D22 +24.1° (c = 0.0133 in chloroform)
 
Derivative Type: Sulfate
CAS Registry Number: 157810-81-6
Manufacturers' Codes: MK-639
Trademarks: Crixivan (Merck & Co.)
Molecular Formula: C36H47N5O4.H2SO4
Molecular Weight: 711.87
Percent Composition: C 60.74%, H 6.94%, N 9.84%, O 17.98%, S 4.50%
Properties: Occurs as the monoethanolate, crystals from absolute ethanol, softens at 135°, mp 150-153° (dec). Converts to hydrate upon loss of ethanol and exposure to moist air.
Melting point: mp 150-153° (dec)
 
Therap-Cat: Antiviral.
Keywords: Antiviral; Peptidomimetics; HIV Protease Inhibitor.